Linda Qu

Dr. Linda Qu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2024 in ChemMedChem
Verified
Journal Article
Open access
ANAthar Nakisa
Athar Nakisa
Lorenzo F SempereLorenzo F Sempere
Lorenzo F Sempere
XCXi Chen
Xi Chen
LQLinda Qu
Linda Qu
DWDaniel Woldring
Daniel Woldring
XHXuefei Huang
Xuefei Huang
Carbohydrate antigen 19–9 (CA 19–9) also known as sialyl Lewis A is a tetrasaccharide overexpressed on a wide range of cancerous cells. CA 19–9 has been detected at elevated levels in sera of patients with various types of malignancies, most prominently pancreatic ductal adenocarcinoma. After its identification in 1979, multiple studies have highlighted the significant roles of CA 19–9 in cancer progression, including facilitating extravasation and eventually metastases, proliferation of cancer cells, and suppression of the immune system. Therefore, CA 19–9 has been considered an attractive target for cancer diagnosis, prognosis, and therapy. This review discusses the synthesis of CA 19–9 antigen, elicitation of antibodies through vaccination, development of anti‐CA 19–9 monoclonal antibodies, and their applications as imaging tracers and therapeutics for a variety of CA 19–9‐positive cancer.

10 November 2023 in HPB
Verified
Journal Article
Closed access
MWMichael M. Wach
Michael M. Wach
LWLaura A. Washburn
Laura A. Washburn
JAJurgis Alvikas
Jurgis Alvikas
LQLinda Qu
Linda Qu
MZMichelle Zhang
Michelle Zhang
STSamer Tohme
Samer Tohme

Verified
Journal Article
Open access
PDF file
Randi Nevins StanulisRandi Nevins Stanulis
Randi Nevins Stanulis
LBLuke Beauchamp
Luke Beauchamp
JPJohn David Pestenariu
John David Pestenariu
SSScot Stanulis
Scot Stanulis
LQLinda Qu
Linda Qu
JKJordan Knepper
Jordan Knepper
Through semi-structured interviews with attending surgeons, this exploratory qualitative study examined ways in which eleven surgeons create conditions for residents to flourish in the clinical learning environment. We conducted interviews with a purposeful sample of eleven surgical faculty from across the United States. The transcripts were deductively coded using VanderWeele’s (2017) flourishing framework, which includes character and virtue, close social relationships, meaning and purpose, and life satisfaction. Through open coding and thematic analysis, we identified three interrelated themes: (1) acting to promote good through mattering, (2) deriving satisfaction from individualizing teaching, and (3) affirming the worth of residents as humans.

3 July 2026 in Reports
Verified
Journal Article
Open access
PDF file
SCSeung Hwan Chung
Seung Hwan Chung
HAHussein Ali-Ahmad
Hussein Ali-Ahmad
AZAndrew Zwyghuizen
Andrew Zwyghuizen
LQLinda Qu
Linda Qu
Background and Clinical Significance: Cutaneous squamous cell carcinoma (CSCC) is a common non-melanoma skin cancer, and while most cases are curable, a small proportion progresses to locally advanced or metastatic disease. As neoadjuvant immunotherapy with PD-1 inhibitors such as cemiplimab becomes more widely adopted, understanding real-world patterns of response remains essential. Case Presentation: We report a case of a man in his 50s with a large, locally advanced CSCC of the left hand in whom neoadjuvant cemiplimab was chosen to reduce tumor burden and preserve hand function when margin-negative resection was unlikely. The patient received four cycles of cemiplimab and demonstrated marked clinical improvement followed by complete pathological response at the primary site upon wide local excision. However, metastatic involvement of the epitrochlear and axillary lymph nodes was identified at surgery despite initial benign imaging. Postoperative PET/CT showed no additional disease, and the patient subsequently underwent axillary dissection and adjuvant cemiplimab with good functional recovery. Conclusions: This case highlights the potential for neoadjuvant cemiplimab to achieve substantial local tumor control and functional preservation while emphasizing the need for careful nodal assessment and ongoing surveillance in patients with very-high-risk CSCC. In cases where baseline cross-sectional staging is not performed, pre-existing occult nodal disease cannot be excluded.

2 November 2026 in Cancers
Verified
Journal Article
Open access
PDF file
CRCallie Rose
Callie Rose
JHJames Hosner
James Hosner
SCSeung Hwan Chung
Seung Hwan Chung
LWLing Wang
Ling Wang
LQLinda Qu
Linda Qu
Background/Objectives: Alpha-fetoprotein (AFP) is often elevated in hepatocellular carcinoma (HCC) and has been linked to poor prognosis. Among HCC subtypes, the association is less defined. We aimed to characterize AFP and their association with prognosis for the fibrolamellar, scirrhous, clear-cell, spindle-cell, and pleomorphic subtypes of HCC. Methods: Patients in the National Cancer Database (NCDB) diagnosed with HCC between 1998–2021, including not otherwise specified (NOS), fibrolamellar, scirrhous, clear-cell, spindle-cell, and pleomorphic were included. Elevated AFP was defined as 400 ng/mL or above. Associations between clinical characteristics, including AFP levels, and HCC subtypes were analyzed using two-sample t-test, chi-square, and Fisher exact tests. Survival was assessed using Kaplan–Meier curves with log-rank tests. Results: The study population included 168,470 patients, of which 166,778 (99.0%) were HCC NOS, followed by 872 (0.5%) clear-cell, 417 (0.2%) fibrolamellar, 251 (0.2%) scirrhous, 136 (0.1%) spindle-cell, and 16 (0.01%) pleomorphic. Elevated AFP was highest in the spindle-cell subtype (30.9%), followed by HCC NOS (29.4%), scirrhous (25.1%), clear-cell (23.4%), and fibrolamellar (15.6%) (p < 0.0001). Elevated AFP was significantly different across stage of disease with elevation in 11.9% of fibrolamellar, 6.8% of scirrhous, 35.7% of spindle-cell, 25.2% of clear-cell, and 17.6% of HCC NOS at stage 2; 22.5%, 50%, 33.3%, 28.2%, and 44.2%, respectively at stage 3; and 13.8%, 30.4%, 31.7%, 42.2%, and 53.2%, respectively, at stage 4 (all p < 0.005). Elevated AFP was associated with decreased survival for the fibrolamellar (9.7 months when elevated vs. 39 months when not elevated), scirrhous (3.8 vs. 24.2) and clear-cell (7.2 vs. 25.9) subtypes (p < 0.0001). Conclusions: Elevated AFP is least prevalent for fibrolamellar HCC, including when stratifying by disease stage, though it is associated with worse survival in that population. AFP elevation may offer important prognostic information when rare subtypes are diagnosed.